These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
51. Novel acetamide derivatives of 2-aminobenzimidazole prevent inflammatory arthritis in rats via suppression of pro-inflammatory mediators. Zubair AM; Malik MNH; Younis W; Malik MAH; Jahan S; Ahmed I; Yuchi A; Mushtaq MN; Tahir R; Sarwar MB; Roman M; Khan AA; Tahir MN; Khan MT; Kharl HAA; Kamran G; Albegali AA; Imran A Inflammopharmacology; 2022 Jun; 30(3):1005-1019. PubMed ID: 35429318 [TBL] [Abstract][Full Text] [Related]
52. Discovery of Thiazole Based Bis Heterocyclic System for Anti- Inflammatory Potential. Tapkir AS; Chitlange SS; Bhole RP Antiinflamm Antiallergy Agents Med Chem; 2017; 16(3):175-192. PubMed ID: 29141567 [TBL] [Abstract][Full Text] [Related]
53. Coumarin Derivatives as Anti-inflammatory and Anticancer Agents. Thomas V; Giles D; Basavarajaswamy GPM; Das AK; Patel A Anticancer Agents Med Chem; 2017; 17(3):415-423. PubMed ID: 27592545 [TBL] [Abstract][Full Text] [Related]
54. Analogue-based design, synthesis and molecular docking analysis of 2,3-diaryl quinazolinones as non-ulcerogenic anti-inflammatory agents. Manivannan E; Chaturvedi SC Bioorg Med Chem; 2011 Aug; 19(15):4520-8. PubMed ID: 21724403 [TBL] [Abstract][Full Text] [Related]
55. Selective cyclooxygenase inhibition and ulcerogenic liability of some newly prepared anti-inflammatory agents having thiazolo[4,5-d]pyrimidine scaffold. Bakr RB; Ghoneim AA; Azouz AA Bioorg Chem; 2019 Jul; 88():102964. PubMed ID: 31075742 [TBL] [Abstract][Full Text] [Related]
56. Synthesis, pharmacological screening and in silico studies of new class of Diclofenac analogues as a promising anti-inflammatory agents. Palkar MB; Singhai AS; Ronad PM; Vishwanathswamy AH; Boreddy TS; Veerapur VP; Shaikh MS; Rane RA; Karpoormath R Bioorg Med Chem; 2014 May; 22(10):2855-66. PubMed ID: 24751552 [TBL] [Abstract][Full Text] [Related]
57. Synthesis, modeling and biological evaluation of some pyrazolo[3,4-d]pyrimidinones and pyrazolo[4,3-e][1,2,4]triazolo[4,3-a]pyrimidinones as anti-inflammatory agents. Tageldin GN; Ibrahim TM; Fahmy SM; Ashour HM; Khalil MA; Nassra RA; Labouta IM Bioorg Chem; 2019 Sep; 90():102844. PubMed ID: 31229797 [TBL] [Abstract][Full Text] [Related]
58. Febuxostat-based amides and some derived heterocycles targeting xanthine oxidase and COX inhibition. Synthesis, in vitro and in vivo biological evaluation, molecular modeling and in silico ADMET studies. Rashad AY; Kassab SE; Daabees HG; Abdel Moneim AE; Rostom SAF Bioorg Chem; 2021 Aug; 113():104948. PubMed ID: 34052736 [TBL] [Abstract][Full Text] [Related]
59. Molecular docking design and one-pot expeditious synthesis of novel 2,5-diarylpyrazolo[1,5-a]pyrimidin-7-amines as anti-inflammatory agents. Aggarwal R; Singh G; Kaushik P; Kaushik D; Paliwal D; Kumar A Eur J Med Chem; 2015 Aug; 101():326-33. PubMed ID: 26160113 [TBL] [Abstract][Full Text] [Related]
60. Design, synthesis, and pharmacological evaluation of novel and selective COX-2 inhibitors based on celecoxib scaffold supported with in vivo anti-inflammatory activity, ulcerogenic liability, ADME profiling and docking study. Abdellatif KRA; Abdelall EKA; Elshemy HAH; Philoppes JN; Hassanein EHM; Kahk NM Bioorg Chem; 2022 Mar; 120():105627. PubMed ID: 35065465 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]